PUBLIC HEALTH, NURSING, MEDICAL SOCIAL WORK

PEDIATRICS ◽  
1957 ◽  
Vol 19 (2) ◽  
pp. 317-324
Author(s):  
Pinchas Robinson
Keyword(s):  
Child Health ◽  
World Health ◽  
Regional Office ◽  
Medical Social Work ◽  
The World ◽  
Health Nursing ◽  
Health Organization ◽  
Opening Paragraph ◽  
North And South America ◽  
North And South

When this column presented the paper by Dr. Lowe on "Observations on the Care of Children in Afghanistan," there was considerable interest in the rather unusual conditions presented. The way children live and are cared for in other countries of the world interests pediatricians, both because of their catholic interest in child health and the possible lessons to be learned from such a study which can be applied in one's own situation. Dr. Robinson has been serving as Consultant in Maternal and Child Health in the Regional Office for South East Asia of the World Health Organization, one of the most populous regions in the world. India itself, as Dr. Robinson indicates in the cold figures of his opening paragraph, has a population larger than that of the 21 American republics, that is of North and South America combined. It is clear that variations within the region must be great and that generalizations must be made with great care.

PUBLIC HEALTH, NURSING AND MEDICAL SOCIAL WORK

PEDIATRICS ◽  
1953 ◽  
Vol 11 (3) ◽  
pp. 290-293
Keyword(s):  
World Health Organization ◽  
Health Program ◽  
International Health ◽  
World Health ◽  
Expert Committee ◽  
Medical Social Work ◽  
The World ◽  
Health Nursing ◽  
Health Organization ◽  
Sales Agents

STANDARDIZATION of terminology for drugs and scientific substances appears to be a highly desirable goal. Exchange of information through publication and individual communication would be far less subject to misinterpretation if nomenclature were precise and unchanged. Furthermore, increase in world travel makes it more necessary than ever that patients, physicians, and pharmacists be able severally to request and comply with requests for drugs without worry about differences in names. International health co-operation and regional health program would obviously benefit from simplification of terminology. The situation has recently been reviewed by P. Blanc, Secretary of the World Health Organization Expert Committee on the International Pharmacopoeia, before the International Pharmaceutical Federation. His paper has been summarized in the Chronicle of the World Health Organization, for November 1952, volume 6, page 322, from which the following extracts are taken: "At first sight it might seem that, for the numerous drugs which are chemical compounds, the chemical names could be used; but the latter are often so complicated that manufacturers and sales agents spontaneously adopt simpler and shorter names. Obviously `riboflavine' sounds better and is more easily remembered than 6:7-dimethyl-9-(D-1'-ribityl)izo-alloxazine. But, unfortunately, the same substance is known elsewhere by the name of `lactoflavine' or `vitamin B2'. Another example may be cited, namely that of the methadone hydrochloride of the Pharmacopoea Internationalis (6-dimethylamino-4,4-diphenyl-3-heptanone), which is known in different countries under the following names: amidone, miadone, diadone, diaminon, mephenon, symoron, etc.

PUBLIC HEALTH, NURSING AND MEDICAL SOCIAL WORK

PEDIATRICS ◽  
1951 ◽  
Vol 8 (4) ◽  
pp. 570-572
Keyword(s):  
Premature Infants ◽  
The United States ◽  
World Health ◽  
Multiple Birth ◽  
Expert Committee ◽  
Medical Social Work ◽  
Incidence And Mortality ◽  
Health Nursing ◽  
Health Organization ◽  
Intrinsic Variable

IN THE summary of the report of the Expert Committee on Prematurity of the World Health Organization, published in this column in February 1951, Dr. Ethel Dunham indicated the concern of the Expert Committee in regard to uniformity of information on the incidence and mortality of prematurity. The need for uniformity is particularly urgent in a field where there are so many intrinsic variable factors. It has been shown time and again that the ability of a premature infant to survive, under the best of care, is closely correlated with the birth weight, which in itself reflects the stage of maturity. In turn, the stage of maturity at a given weight is affected by sex, race, and whether the child is a single or one of a multiple birth. Uniformly, at a particular stage of maturity, male infants are larger than female, single births are larger than multiple births and, in the United States, white babies are larger than Negro babies. These considerations underline the danger of misinterpretation of so-called over-all rates for the incidence of prematurity and for the mortality of premature infants. For example, at any given weight, Negro premature infants are probably more mature and consequently have a better chance of surviving.

INTERNATIONAL NEWS AND REPORTS

PEDIATRICS ◽  
1948 ◽  
Vol 2 (4) ◽  
pp. 499-504
Keyword(s):  
Child Health ◽  
Malaria Control ◽  
Venereal Disease ◽  
World Health ◽  
International News ◽  
World Health Assembly ◽  
The World ◽  
Health Organization ◽  
First World ◽  
And Child Health

The First World Health Assembly convened in Geneva, Switzerland, on June 24, 1948, and remained in session until July 24. Fifty-four nations sent delegates. The work of this First Assembly centered around the development of a program of action for the World Health Organization. After discussions of a long list of possible activities, the Assembly adopted a program which established certain priorities for the work of the Organization during the coming year. Malaria control, maternal and child health, tuberculosis and venereal disease control, nutrition and environmental sanitation were placed in the top priority. To carry out these priority programs the WHO authorized the appointment of expert committees and the establishment of appropriate sections of work in the secretariat of the Organization.

scholarly journals E-HEALTH NURSING VIRTUAL REALITY TREND PADA PASIEN SKIZOFRENIA GUNA MENINGKATKAN KESEHATAN MENTAL: SYSTEMATIC REVIEW

2021 ◽  
pp. 172-180
Author(s):  
Fitrio Deviantony ◽  
Grysha Viofananda ◽  
Nurul Hidayah ◽  
Nadhifa Eriyanti
Keyword(s):  
Mental Health ◽  
Systematic Review ◽  
Virtual Reality ◽  
World Health Organization ◽  
World Health ◽  
Reality Therapy ◽  
Virtual Reality Therapy ◽  
The World ◽  
Health Nursing ◽  
Health Organization

permasalahan serius di dunia dan Indonesia. Data dari World Health Organization sekitar 21 juta orang mengalami skizofrenia. Prevalensi skizofrenia di Indonesia mengalami peningkatan proporsi per 1000 penduduk (1,7%) pada tahun 2013 menjadi (7%) pada tahun 2018. Faktanya terapi keperawatan untuk halusinasi belum optimal sedangkan teknologi terus berkembang seperti Virtual Reality (VR). VR mampu menurunkan gejala pada skizofrenia dengan kemampuan membuat perilaku interaktif dan tersimpan dalam otak agar tidak menimbulkan halusinasi. Teknologi ini digunakan untuk mengetahui manfaat E-Health Nursing VR sebagai terapi halusinasi pada pasien skizofrenia. Metode penelitian menggunakan systematic review dari 5 database yaitu Nature, Frontiers, BMC, Science Direct, NEJM sehingga didapat total 55 literatur. Mayoritas 63% mengulas terapi VR untuk mengurangi halusinasi pada skizofrenia. Perkembangan manfaat VR diverifikasi dalam beberapa pengobatan: skizofrenia, PTSD, kecemasan, akrofobia, ganguan citra tubuh, claustrophobia, dan lain-lain. Beberapa studi skizofrenia menyatakan terapi VR sangat efektif menangani delusi, halusinasi, gejala kepribadian skizoid. VR juga berguna dalam rehabilitas kognitif pada orang dewasa atau anak-anak autis dalam keterampilan dan kemandirian. Kesimpulan penelitian ini adalah VR terbukti efektif sebagai terapi kesehatan jiwa di masa mendatang. Disisi lain terdapat terapi psikologis pilihan seperti terapi perilaku kognitif, dan psikoterapi interpersonal. Oleh karenanya diperlukan kombinasi terapi VR dengan terapi komplementer tersebut dalam mengurangi halusinasi pada skizofrenia.   Mental health become a severe problem in the world and Indonesia. Data from the World Health Organization (WHO, 2016) estimated that 21 million people have schizophrenia. The prevalence of schizophrenia in Indonesia has increased proportion per 1000 population (1,7%) in 2013 to (7%) in 2018. In fact of nursing, therapy for hallucination is not optimal while constantly evolving technology such as Virtual Reality (VR). VR can reduce symptoms in schizophrenia with the ability to create interactive behavior and stored in the brain in order to cause hallucinations. The objective of this study was to review the benefit of VR as a hallucination therapy in schizophrenia patients. This research used a systematic literature review from five databases Nature, Frontiers, BMC, Science Direct, NEJM, and resulted in the retrieval of 55 papers. The majority of a result found a 63% review in Virtual Reality therapy can reduce hallucination in schizophrenia. VR is a technology browser and manipulator sensory environment in real-time 3D. The progressing benefit of VR verified in the treatment of schizophrenia, PSTD, anxiety, acrophobia, body image disorder, claustrophobia, and others. Some studies of schizophrenia declare that virtual reality therapy is effective in treating delusions, hallucinations, and a symptom of schizoid behavior. VR also has benefits in cognitive rehabilitation in adults or children with autism's inability and self-reliance. VR has a bright future as the treatment of mental health. The progressing of technology and research has an excellent opportunity for VR to reduce schizophrenia. Moreover, there is psychological therapy, such as cognitive-behavioral therapy and interpersonal psychotherapy. Therefore a combination needed of virtual therapy with the complementary therapy for reducing hallucination in schizophrenia.

scholarly journals The WHO European health for all database

2003 ◽  
Vol 7 (6) ◽  
Author(s):  
Keyword(s):  
World Health ◽  
Health Statistics ◽  
Regional Office ◽  
International Context ◽  
Health Trends ◽  
Wide Range ◽  
The World ◽  
European Health ◽  
Health Organization ◽  
Health Situation

The European health for all database provides easy and rapid access to a wide range of basic health statistics (indicators) for the 51 Member States of the World Health Organization (WHO) European Region. It was developed by the WHO Regional Office for Europe in the mid 1980s to support the monitoring of health trends in the Region. The database is a helpful tool for international comparison and for assessing the health situation and trends in any European country in an international context.

scholarly journals Implementation of the World Health Organization Regional Office for Africa Stepwise Laboratory Quality Improvement Process Towards Accreditation

2016 ◽  
Vol 5 (1) ◽  
Author(s):  
Jean-Bosco Ndihokubwayo ◽  
Talkmore Maruta ◽  
Nqobile Ndlovu ◽  
Sikhulile Moyo ◽  
Ali Ahmed Yahaya ◽  
...  
Keyword(s):  
Quality Improvement ◽  
World Health Organization ◽  
Continuous Quality Improvement ◽  
World Health ◽  
Regional Office ◽  
Quality Improvement Process ◽  
Continuous Quality ◽  
The World ◽  
Health Organization ◽  
World Health Organization Regional

Background: The increase in disease burden has continued to weigh upon health systems in Africa. The role of the laboratory has become increasingly critical in the improvement of health for diagnosis, management and treatment of diseases. In response, the World Health Organization Regional Office for Africa (WHO AFRO) and its partners created the WHO AFRO Stepwise Laboratory (Quality) Improvement Process Towards Accreditation (SLIPTA) program.SLIPTA implementation process: WHO AFRO defined a governance structure with roles and responsibilities for six main stakeholders. Laboratories were evaluated by auditors trained and certified by the African Society for Laboratory Medicine. Laboratory performance was measured using the WHO AFRO SLIPTA scoring checklist and recognition certificates rated with 1–5 stars were issued.Preliminary results: By March 2015, 27 of the 47 (57%) WHO AFRO member states had appointed a SLIPTA focal point and 14 Ministers of Health had endorsed SLIPTA as the desired programme for continuous quality improvement. Ninety-eight auditors from 17 African countries, competent in the Portuguese (3), French (12) and English (83) languages, were trained and certified. The mean score for the 159 laboratories audited between May 2013 and March 2015 was 69% (median 70%; SD 11.5; interquartile range 62–77). Of these audited laboratories, 70% achieved 55% compliance or higher (2 or more stars) and 1% scored at least 95% (5 stars). The lowest scoring sections of the WHO AFRO SLIPTA checklist were sections 6 (Internal Audit) and 10 (Corrective Action), which both had mean scores below 50%.Conclusion: The WHO AFRO SLIPTA is a process that countries with limited resources can adopt for effective implementation of quality management systems. Political commitment, ownership and investment in continuous quality improvement are integral components of the process.

scholarly journals European Immunization Week 2008: Progress towards regional goals

2008 ◽  
Vol 13 (16) ◽  
Author(s):  
Collective WHO
Keyword(s):  
World Health Organization ◽  
Public Awareness ◽  
Political Support ◽  
World Health ◽  
Childhood Immunisation ◽  
Regional Office ◽  
The Public ◽  
National Immunisation ◽  
The World ◽  
Health Organization

The World Health Organization (WHO) Regional Office for Europe established the European Immunization Week (EIW, http://www.euro.who.int/vaccine) in 2005 for three reasons: 1) to raise public awareness of the benefits of immunisation, 2) to support national immunisation systems, and 3) to provide a framework for mobilising public and political support for governmental efforts to protect the public through universal childhood immunisation.

World Health Organization

1949 ◽  
Vol 3 (3) ◽  
pp. 546-548
Keyword(s):  
Costa Rica ◽  
World Health Organization ◽  
Western Hemisphere ◽  
World Health ◽  
Director General ◽  
Regional Office ◽  
The World ◽  
Pan American ◽  
Health Organization

On March 22, 1949 Costa Rica ratified the constitution of the World Health Organization and on April 13 WHO was joined by Honduras, thus bringing the membership of the organization to 61.The agreement by which the Pan American Sanitary Organization became the regional office for WHO in the western hemisphere was signed on May 24, 1949 in Washington by Dr. Brock Chisholm, Director General of WHO and Dr. Fred L. Soper, Director of the Pan American Sanitary Office. Under the agreement the office was to adopt and promote health and sanitary conventions and programs in the western hemisphere provided they were “compatible with the policy and programs of the World Health Organization and are separately financed.”

Sign in / Sign up

Export Citation Format

Share Document